For more than a decade, formulation and delivery scientists have relied on IBC Life Sciences for a forum that has consistently provided them with the knowledge and tools they need for the advancement of next-generation biologics and protein therapeutics.

In its 13th year, Formulation and Delivery Strategies for Biologics & Protein Therapeutics is once again a must-attend event, delivering a combination of case studies with new and unpublished data, recommended best practices and perspectives on regulatory issues- making it the industry's premier formulation and delivery conference.

By Attending You Will:

• Gain greater insight on the influence of aggregation and characterization for realizing stable, safe and effective formulation through regulatory perspectives from FDA's Susan Kirshner, Ph.D.
• Understand the intricacies of particle identification and characterization for stable, safe and effective formulation with insights and strategies from the University of Colorado - Boulder, Merck, Pfizer, KBI Biopharma and Coriolis Pharma.
• Apply predictive tools for achieving stable and high-protein concentration formulations using case studies and unpublished data from Abbott, ImClone Systems, Johnson & Johnson , Massachusetts Institute of Technology GlaxoSmithKline, the University of New Hampshire MedImmune, Hoffman-La Roche, Genentech, and Gilead Sciences
• Meet time-to-market and clinical goalswith synchronized formulation and device development by employing approaches and tactics from Eli Lilly and West Pharmaceutical Services Inc.
• Hear the latest developments on localized and targeted delivery with case studies and unpublished data from MannKind, 3M Drug Delivery Systems, Bayer HealthCare, Novartis and the University of Kansas

Plus, Bonus Networking & Social Functions

Held concurrently with IBC's BioProcess International™ Conference and Exhibition, Formulation & Delivery attendees have access to the BPI exhibit floor, posters, industry leading keynote presentations and social functions, giving you the opportunity to visit with more than 150 suppliers of bioprocess technology and services and network with over 1,500 colleagues and industry leaders in attendance.

Who Should Attend:

Scientists, technicians and other specialist working, formulation, analytical development, regulatory affairs, pharmaceutical development, quality assurance/quality operations, technical operations/ manufacturing sciences, drug product manufacturing, clinical supply chain, procurement, process development and engineering will benefit from this program.